An experimental multiplex PCR/RT-PCR for detection of the main viruses associated with equine neurological disease.

An experimental multiplex PCR/RT-PCR assay was developed for the simultaneous detection of multiple viruses responsible for neurological diseases in horses, allowing for more efficient and comprehensive diagnosis.

Background and Importance

• Equine neurological diseases caused by viruses lead to significant illness and death in horses worldwide.
• Accurate and rapid diagnosis is crucial for effective treatment and control of outbreaks.
• Several viruses are known to cause encephalitis in horses, including rabies virus, equine herpesvirus type 1, alphaviruses, and flaviviruses.

Aim of the Study

• To develop and describe a multiplex PCR/RT-PCR assay capable of detecting key viruses associated with equine neurological conditions in a single test.
• The assay aims to simultaneously identify rabies virus, equine herpesvirus type 1, specific alphaviruses, and flaviviruses.

Viruses Targeted

• Rabies virus (RABV)
• Equine herpesvirus type 1 (EHV-1)
• Alphaviruses:
  • Venezuelan equine encephalitis virus (VEEV)
  • Eastern equine encephalitis virus (EEEV)
  • Western equine encephalitis virus (WEEV)
  • Madariaga virus (MADV)
• Flaviviruses:
  • West Nile virus (WNV)
  • Saint Louis encephalitis virus (SLEV)
  • Rocio virus (ROCV)
  • Japanese encephalitis virus (JEV)

Methodology

• Development of an end-point multiplex PCR/RT-PCR assay combining multiple primer sets targeting conserved sequences in these viruses’ genomes.
• Each virus or group produces a PCR product of a distinct size, allowing differentiation by gel electrophoresis.
• Experimental validation performed on specific viruses representative of each group, especially for MADV and ROCV.
• Primer designs for viruses like EEEV, WEEV, WNV, SLEV, and JEV are based on sequence conservation, suggesting potential applicability even if not all were directly tested.

Key Results

• The multiplex assay successfully amplified all targets individually and when combined.
• Detected fragments of specific sizes:
  • Alphavirus: 381 base pairs (experimentally evaluated for MADV; potentially applicable to EEEV and WEEV)
  • EHV-1: 255 base pairs
  • Rabies virus: 173 base pairs
  • VEEV: 119 base pairs
  • Flavivirus: 97-101 base pairs (experimentally validated with ROCV; potentially applicable to WNV, SLEV, and JEV)
• Demonstrated high analytical sensitivity (ability to detect low amounts of viral genetic material) and specificity (ability to uniquely detect target viruses without cross-reactivity).

Implications and Benefits

• Provides a comprehensive diagnostic tool capable of detecting multiple equine neurotropic viruses in a single assay, saving time and resources.
• Reduces diagnostic turnaround time compared to testing for each virus separately.
• Facilitates early and accurate identification of viral causes, aiding in timely implementation of control and prevention measures.
• Potential cost savings for veterinary diagnostic laboratories and horse owners.
• May improve epidemiological surveillance by enabling broader screening for multiple viruses simultaneously.

Conclusions

• The article reports the successful development and initial validation of a multiplex PCR/RT-PCR assay targeting the main viral agents linked to neurological disease in horses.
• This assay has the potential to enhance diagnostic capabilities in veterinary medicine, particularly in managing equine encephalitis and similar conditions caused by viral infections.
• Further validation with field samples and diverse viral strains could strengthen the assay’s clinical utility.